Enanta Pharmaceuticals Financials

$102.8 M

Revenue FY, 2017

$1.8 B

Mkt cap, 23-Apr-2018
Net income (FY, 2017)17.7 M
EBIT (FY, 2017)24.6 M
Cash, 30-Sep-201765.7 M

Revenue/Financials

Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

32.1 m47.7 m160.9 m88.3 m102.8 m

Revenue growth, %

49%237%(45%)

R&D expense

40.5 m57.5 m

General and administrative expense

17 m20.7 m

Operating expense total

57.4 m78.2 m

Depreciation and amortization

2.1 m

EBIT

9 m19 m124.1 m30.8 m24.6 m

EBIT margin, %

28%40%77%35%24%

Interest expense

31 k18 k8 k45 k40 k

Interest income

248 k467 k968 k1.7 m2.5 m

Pre tax profit

19.3 m125.5 m32.6 m26.9 m

Income tax expense

15.2 m(46.5 m)(10.9 m)(9.2 m)

Net Income

9.6 m34.4 m79 m21.7 m17.7 m

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

42.1 m77.5 m57.4 m11.6 m48.4 m13 m14 m10.4 m9 m

R&D expense

4.6 m4.5 m5.4 m6.3 m9 m9.1 m10.8 m12.5 m13 m

General and administrative expense

2.6 m2.8 m3.4 m3.6 m3.8 m4.4 m4.3 m4.9 m5.5 m

Operating expense total

7.2 m7.3 m8.8 m9.9 m12.9 m13.6 m15.1 m17.5 m18.5 m

EBIT

34.9 m70.2 m48.6 m1.7 m35.6 m(565 k)(1.1 m)(7 m)(9.5 m)

EBIT margin, %

83%91%85%15%73%(4%)(8%)(68%)(106%)

Interest expense

5 k2 k2 k2 k12 k11 k11 k12 k8 k

Interest income

106 k127 k229 k304 k356 k408 k474 k549 k572 k

Pre tax profit

34.9 m2 m35.9 m(642 k)(6.5 m)(9 m)

Income tax expense

15.1 m(28.5 m)(20 m)428 k(9.7 m)(1.6 m)(434 k)1.5 m3.6 m

Net Income

39.5 m42 m70.8 m73.2 m26.2 m24.5 m23.5 m(5 m)(10.4 m)

Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

8.9 m30.7 m21.7 m16.6 m65.7 m

Accounts Receivable

808 k1.7 m15.3 m12.8 m10.6 m

Inventories

1.6 m1.6 m8.3 m9.2 m3.5 m

Current Assets

104.7 m108 m170.6 m232.2 m237.8 m

PP&E

1.1 m1.8 m5.9 m8 m8 m

Total Assets

117 m155.4 m246 m281.3 m326.6 m

Accounts Payable

1.5 m1.9 m1.5 m3.4 m3.7 m

Short-term debt

Current Liabilities

4.5 m4.7 m6.7 m7.9 m21 m

Long-term debt

Total Liabilities

11.3 m25 m

Additional Paid-in Capital

217.7 m221.6 m230 m242.1 m256.2 m

Retained Earnings

(107.5 m)(73 m)6 m27.6 m45.4 m

Total Equity

110.5 m148.7 m236.2 m269.9 m301.7 m

Financial Leverage

1.1 x1 x1 x1 x1.1 x

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

26.4 m34.1 m25.8 m19.8 m46.2 m56.4 m24.8 m20.6 m19.2 m

Accounts Receivable

399 k76.6 m7.1 m11.7 m17.9 m13 m14 m10.4 m9 m

Current Assets

111.7 m185.1 m177.8 m172.6 m209 m242.7 m241.8 m224.1 m190.6 m

PP&E

1.6 m1.9 m2.3 m2.6 m7.9 m7.7 m7.5 m8.3 m8.5 m

Total Assets

159.5 m215.4 m245.9 m237.8 m278.4 m281.6 m281.9 m278.4 m279 m

Accounts Payable

1.3 m567 k2.3 m1.6 m2.8 m2.6 m2 m2 m4.1 m

Current Liabilities

4.3 m19.9 m19.8 m7.3 m10.9 m12 m9.6 m6.4 m9.2 m

Additional Paid-in Capital

220.7 m224.6 m226.3 m228 m232.1 m235.5 m239.3 m245.4 m248.7 m

Retained Earnings

(68 m)(31 m)(2.3 m)168 k32.2 m30.5 m29.4 m22.7 m17.3 m

Total Equity

153 m193.7 m224.2 m228.3 m264.3 m266.4 m269 m268.2 m266 m

Financial Leverage

1 x1.1 x1.1 x1 x1.1 x1.1 x1 x1 x1 x

Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

9.6 m34.4 m79 m21.7 m17.7 m

Depreciation and Amortization

221 k352 k639 k1.7 m2.1 m

Accounts Receivable

241 k(916 k)(14 m)2.4 m2.2 m

Inventories

(307 k)568 k(6.7 m)(964 k)3.5 m

Accounts Payable

115 k399 k(543 k)1.5 m633 k

Cash From Operating Activities

10.7 m20.2 m76.7 m35.8 m52.7 m

Purchases of PP&E

(606 k)(1 m)(2.3 m)(4.7 m)(2.5 m)

Cash From Investing Activities

(69.2 m)497 k(88.2 m)(43.7 m)(4.6 m)

Cash From Financing Activities

56.9 m1.2 m2.5 m2.7 m1 m

Interest Paid

Income Taxes Paid

148 k40.1 m12.6 m1.6 m

Quarterly

USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

39.5 m42 m70.8 m73.2 m26.2 m24.5 m23.5 m(5 m)(10.4 m)

Depreciation and Amortization

242 k129 k270 k435 k339 k772 k1.2 m493 k1 m

Accounts Receivable

409 k(74.9 m)(5.4 m)(10 m)(2.6 m)2.3 m1.3 m2.4 m3.9 m

Accounts Payable

(190 k)(1.3 m)488 k(332 k)149 k1.2 m677 k(1.3 m)688 k

Cash From Operating Activities

25.1 m(5.6 m)93.3 m79 m30 m40 m37.9 m3.1 m143 k

Purchases of PP&E

(543 k)(256 k)(356 k)(756 k)(2.2 m)(3.7 m)(4.3 m)(953 k)(1.5 m)

Cash From Investing Activities

(8.7 m)7 m(100.5 m)(92.3 m)(5.6 m)(6.1 m)(37.5 m)865 k2.7 m

Cash From Financing Activities

1.1 m2 m2.3 m2.4 m146 k676 k2.6 m31 k(180 k)

Income Taxes Paid

66 k22.1 m39.6 m5.7 m5.7 m9.1 m1 m1 m

Ratios

USDY, 2017

Revenue/Employee

1.4 m

Financial Leverage

1.1 x
Report incorrect company information